Literature DB >> 17590230

Sphingomonas astaxanthinifaciens sp. nov., a novel astaxanthin-producing bacterium of the family Sphingomonadaceae isolated from Misasa, Tottori, Japan.

Dalal Asker1, Teruhiko Beppu, Kenji Ueda.   

Abstract

A red-pigmented, Gram-negative, motile, strictly aerobic, mesophilic, oval- or short rod-shaped bacterium (TDMA-17(T)) was isolated from fresh water collected at Misasa, a radioactive site in Japan. TDMA-17(T) was slightly tolerant against gamma-ray irradiation, and effectively produced carotenoids (2.8 mg g(-1) dry cells) including, astaxanthin and astaxanthin isomers. Phylogenetic analysis based on 16S rRNA gene sequences placed TDMA-17(T) in a distinct lineage in the family Sphingomonadaceae, and the highest degree of sequence similarity determined were to Sphingomonas aerolata NW12(T) (94.5%), Sphingomonas aurantiaca MA101b(T) (94.0%), Sphingomonas melonis DAPP-PG 224(T) (94.0%), Sphingomonas asaccharolytica IFO 15499(T) (93.9%) and Sphingomonas abaci C42(T) (93.9%). The major fatty acids were C(17 : 1)omega6c (33.0%) and C(18 : 1)omega7c (20.8%). The DNA G+C content was 67.7 mol%. The presence of Q-10 as the main ubiquinone, the presence of Sphingomonadaceae-specific sphingoglycolipid in the polar lipid profiles, the presence of 2-hydroxy fatty acids and the absence of 3-hydroxy fatty acids supported the identification of this strain as a member of the genus Sphingomonas sensu stricto. Phylogenetic distinctiveness and unique phenotypic characteristics differentiated strain TDMA-17(T) from the closely related Sphingomonas species. The results of polyphasic taxonomic analyses suggested that TDMA-17(T) represents a novel Sphingomonas species, for which the name Sphingomonas astaxanthinifaciens sp. nov. is proposed. The type strain is TDMA-17(T) (=NBRC 102146=CCUG 53608).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17590230     DOI: 10.1111/j.1574-6968.2007.00760.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  7 in total

1.  Sphingomonas rosea sp. nov. and Sphingomonas swuensis sp. nov., rosy colored β-glucosidase-producing bacteria isolated from soil.

Authors:  Sathiyaraj Srinivasan; Jae-Jin Lee; Myung Kyum Kim
Journal:  J Microbiol       Date:  2011-09-02       Impact factor: 3.422

2.  Biodiversity and physiological characteristics of Antarctic and Arctic lichens-associated bacteria.

Authors:  Yung Mi Lee; Eun Hye Kim; Hong Kum Lee; Soon Gyu Hong
Journal:  World J Microbiol Biotechnol       Date:  2014-07-08       Impact factor: 3.312

3.  Genomewide characterisation of the genetic diversity of carotenogenesis in bacteria of the order Sphingomonadales.

Authors:  Shivakumara Siddaramappa; Vandana Viswanathan; Saravanamuthu Thiyagarajan; Anushree Narjala
Journal:  Microb Genom       Date:  2018-04-05

Review 4.  Optimization of microbial cell factories for astaxanthin production: Biosynthesis and regulations, engineering strategies and fermentation optimization strategies.

Authors:  Mostafa Basiony; Liming Ouyang; Danni Wang; Jiaming Yu; Liming Zhou; Mohan Zhu; Xuyuan Wang; Jie Feng; Jing Dai; Yijie Shen; Chengguo Zhang; Qiang Hua; Xiuliang Yang; Lixin Zhang
Journal:  Synth Syst Biotechnol       Date:  2022-02-18

5.  Carotenoids play a positive role in the degradation of heterocycles by Sphingobium yanoikuyae.

Authors:  Xiaorui Liu; Zhonghui Gai; Fei Tao; Hongzhi Tang; Ping Xu
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

6.  Production of the Marine Carotenoid Astaxanthin by Metabolically Engineered Corynebacterium glutamicum.

Authors:  Nadja A Henke; Sabine A E Heider; Petra Peters-Wendisch; Volker F Wendisch
Journal:  Mar Drugs       Date:  2016-06-30       Impact factor: 5.118

7.  Genome mining of astaxanthin biosynthetic genes from Sphingomonas sp. ATCC 55669 for heterologous overproduction in Escherichia coli.

Authors:  Tian Ma; Yuanjie Zhou; Xiaowei Li; Fayin Zhu; Yongbo Cheng; Yi Liu; Zixin Deng; Tiangang Liu
Journal:  Biotechnol J       Date:  2015-12-07       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.